SARA-CoV-2 Viral Transport Medium PCR Storage 25 / 50 Tests/Box

KISSH Transport and Preservation Medium

SARA-CoV-2 Viral Transport Medium(PCR Storage)

Intended Use:

Transport and Preservation Medium is intended for the collection, storage and transport of 2019-nCoV, Viruses, Chlamydiae, mycoplasma or ureaplasma specimens.

Instruction of Operation:

Features:

• Suitable to collect 3-10 samples for mix testing.
• High efficiency, save Nucleic Acid Test Reagents.
• Optional swab of Nasopharyngeal and Oropharynx.
• To avoid biological pollution.

Sampling Methods

• Open the packaging box of the collection kit, take the corresponding sampling swab according to different sampling parts, tear it from the easy to tear mouth mark, and take it out. Nasopharynx is sampled according to the following methods, and others are sampled according to the relevant sampling requirements. -Throat sampling: first press the tongue with the tongue plate, and then extend the swab swab into the throat to wipe the bilateral pharyngeal tonsils and posterior pharyngeal wall, avoid touching the tongue, gently turn the wipe to fully sample. - Nasal sampling: the swab graft head is gently inserted into the nose and palate in the nasal canal, stay for 15-30 seconds and gently rotate 3-5 times, and pull out the swab. For bilateral nostrils samples, repeat with another swab.
• After sampling, take out the storage tube, unscrew the tube cover, and put the sampling swab into the storage tube quickly. -Soak the sampling swab graft head in the storage fluid, break the sampling swab, and discard the sampling handle. - Turn the tube cover immediately, mark the relevant sample information on the storage tube label or paste the bar code label.

Shenzhen Kisshealh Biotechnology Co., Ltd., located in the Pingshan District, Shenzhen, P.R. China. is a diagnostics company focused on the development and manufacture of IVD tests at the Point-of-Care with highly innovative proprietary technology.

We focused on the emerging markets of in vitro pathological diagnosis and immunodiagnosis. We developed, manufactured and successfully launched the in vitro immunodiagnosis platform for cancer and the POCT for infectious, genetic and chronic diseases.

<span style="color: rgb(33, 33, 33); text-transform: none; text-indent: 0px; letter-spacing: normal;" initial;"="" initial;="" 0px;="" normal;="" 255);="" 255,="" rgb(255,="" 2;="" !important;="" inline="" none;="" 600;="" 14px;="" sans-serif;="" arial,="" roboto,="" w3",="" gb="" sans="" "hiragino="" gb",="" hei",="" micro="" "wenquanyi="" sans",="" "droid="" arimo,="" freesans,="" yahei",="" "microsoft="" helvetica,="" grande",="" "lucida="" ui",="" segoe="">At Kissh we work every day to shape the future of in-vitro diagnostic testing. And our people are our best asset, the reason for our track record and our strength while we are moving forward. We live by our fundamental values and incorporate them in everything that we do. Our best asset is ‘Step Forward Every Second’